About C5a anaphylatoxin chemotactic receptor 1
C5a anaphylatoxin chemotactic receptor 1 (C5AR1) is a protein
from Homo sapiens identified by UniProt accession
P21730, 350 residues long.
MolForge cross-references it against 0 known binders and
499 disease associations.
Target properties
| Protein name | C5a anaphylatoxin chemotactic receptor 1 |
| UniProt accession | P21730 |
| Gene | C5AR1 |
| Organism | Homo sapiens |
| Length | 350 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (499)
Diseases linked to this target (Open Targets).
- anti-neutrophil cytoplasmic antibody-associated vasculitis · score 0.47
- Granulomatosis with Polyangiitis · score 0.46
- microscopic polyangiitis · score 0.46
- immune system disease · score 0.37
- anti-neutrophil antibody associated vasculitis · score 0.29
- vasculitis · score 0.28
- glioblastoma multiforme · score 0.27
- ovarian cancer · score 0.25
- breast adenocarcinoma · score 0.17
- head and neck squamous cell carcinoma · score 0.16
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P21730-F1 | alphafold | PREDICTED | 85.73 | — |
Amino-acid sequence (350 residues)
MDSFNYTTPD YGHYDDKDTL DLNTPVDKTS NTLRVPDILA LVIFAVVFLV GVLGNALVVW VTAFEAKRTI NAIWFLNLAV ADFLSCLALP ILFTSIVQHH HWPFGGAACS ILPSLILLNM YASILLLATI SADRFLLVFK PIWCQNFRGA GLAWIACAVA WGLALLLTIP SFLYRVVREE YFPPKVLCGV DYSHDKRRER AVAIVRLVLG FLWPLLTLTI CYTFILLRTW SRRATRSTKT LKVVVAVVAS FFIFWLPYQV TGIMMSFLEP SSPTFLLLKK LDSLCVSFAY INCCINPIIY VVAGQGFQGR LRKSLPSLLR NVLTEESVVR ESKSFTRSTV DTMAQKTQAV
Explore C5a anaphylatoxin chemotactic receptor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets